152 related articles for article (PubMed ID: 16499776)
21. Multidrug resistance in epilepsy: a pharmacogenomic update.
Tate SK; Sisodiya SM
Expert Opin Pharmacother; 2007 Jul; 8(10):1441-9. PubMed ID: 17661727
[TBL] [Abstract][Full Text] [Related]
22. Is refractory epilepsy due to genetically determined resistance to antiepileptic drugs?
Pedley TA; Hirano M
N Engl J Med; 2003 Apr; 348(15):1480-2. PubMed ID: 12686705
[No Abstract] [Full Text] [Related]
23. [An association between the FABP2 gene polymorphism and efficacy of valproates].
Aksenova MG; Burd SG; Kachalin EIu; Avakian GN; Badalian OL; Savenkov AA; Tertyshnik OIu; Dorofeeva MIu; Belousova ED; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):42-5. PubMed ID: 17310796
[TBL] [Abstract][Full Text] [Related]
24. Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients.
Sayyah M; Kamgarpour F; Maleki M; Karimipoor M; Gharagozli K; Shamshiri AR
Epileptic Disord; 2011 Jun; 13(2):155-65. PubMed ID: 21636342
[TBL] [Abstract][Full Text] [Related]
25. Where is the evidence that p-glycoprotein limits brain uptake of antiepileptic drug and contributes to drug resistance in epilepsy?
Anderson GD; Shen DD
Epilepsia; 2007 Dec; 48(12):2372-4. PubMed ID: 18088270
[No Abstract] [Full Text] [Related]
26. Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy.
Haerian BS; Lim KS; Mohamed EH; Tan HJ; Tan CT; Raymond AA; Wong CP; Wong SW; Mohamed Z
Seizure; 2011 Sep; 20(7):546-53. PubMed ID: 21530324
[TBL] [Abstract][Full Text] [Related]
27. MDR1 gene polymorphisms and clinical relevance.
Li YH; Wang YH; Li Y; Yang L
Yi Chuan Xue Bao; 2006 Feb; 33(2):93-104. PubMed ID: 16529292
[TBL] [Abstract][Full Text] [Related]
28. The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis.
Farnood A; Naderi N; Moghaddam SJ; Noorinayer B; Firouzi F; Aghazadeh R; daryani NE; Zali MR
Int J Colorectal Dis; 2007 Sep; 22(9):999-1003. PubMed ID: 17242936
[TBL] [Abstract][Full Text] [Related]
29. Effect of treatment and additional disease on pharmacokinetic of valproic acid in children with epilepsy.
Juárez-Olguín H; Lugo-Goytia G; Flores-Murrieta F; Ruiz-García M; Lares Asseff I; Flores Pérez J
Rev Invest Clin; 2010; 62(6):516-23. PubMed ID: 21416779
[TBL] [Abstract][Full Text] [Related]
30. Association between C3435T polymorphism of MDR1 gene and the incidence of drug-resistant epilepsy in the population of Polish children.
Stasiołek M; Romanowicz H; Połatyńska K; Chamielec M; Skalski D; Makowska M; Smolarz B
Behav Brain Funct; 2016 Jul; 12(1):21. PubMed ID: 27391700
[TBL] [Abstract][Full Text] [Related]
31. [Personalized medicine for epilepsy based on the pharmacogenomic testing].
Yoshida S; Sugawara T; Nishio T; Kaneko S
Brain Nerve; 2011 Apr; 63(4):295-9. PubMed ID: 21441631
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacogenetic criteria of drug-resistant epilepsy].
Oros MM
Lik Sprava; 2012 Dec; (8):71-4. PubMed ID: 23786015
[TBL] [Abstract][Full Text] [Related]
33. Lack of association between polymorphism in ABCC2 gene and response to antiepileptic drug treatment in Croatian patients with epilepsy.
Sporis D; Bozina N; Basić S; Lovrić M; Babić T; Susak I; Marković I
Coll Antropol; 2013 Mar; 37(1):41-5. PubMed ID: 23697249
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics and antiepileptic drugs.
Spear BB
Epilepsia; 2001; 42 Suppl 5():31-4. PubMed ID: 11887965
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.
Dombrowski SM; Desai SY; Marroni M; Cucullo L; Goodrich K; Bingaman W; Mayberg MR; Bengez L; Janigro D
Epilepsia; 2001 Dec; 42(12):1501-6. PubMed ID: 11879359
[TBL] [Abstract][Full Text] [Related]
36. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
[TBL] [Abstract][Full Text] [Related]
37. Antiepileptic activity of 1,3-dihexadecanoylamino-2-valproyl-propan-2-ol, a prodrug of valproic acid endowed with a tropism for the central nervous system.
Mergen F; Lambert DM; Goncalves Saraiva JC; Poupaert JH; Dumont P
J Pharm Pharmacol; 1991 Nov; 43(11):815-6. PubMed ID: 1686916
[No Abstract] [Full Text] [Related]
38. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
39. Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis.
Ogusu N; Saruwatari J; Nakashima H; Noai M; Nishimura M; Deguchi M; Oniki K; Yasui-Furukori N; Kaneko S; Ishitsu T; Nakagaswa K
PLoS One; 2014; 9(11):e111066. PubMed ID: 25372290
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene.
Dericioglu N; Babaoglu MO; Yasar U; Bal IB; Bozkurt A; Saygi S
Epilepsy Res; 2008 Jul; 80(1):42-6. PubMed ID: 18436433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
